Sharlene Gill: Updates on emerging molecular targets in Colorectal Cancer
Sharlene Gill, Medical Oncologist and Medical Director, Staff Wellness and Engagement at BC Cancer, shared a recent article on LinkedIn:
“Happy to share our ASCO Daily News update on emerging molecular targets in Colorectal Cancer.
Congrats to our GI fellow and soon to be staff Dr JP SolarVasconcelos. BC Cancer.”
Title: Understanding and Integrating Emerging Targets Into Treatment Decision-Making for Metastatic CRC
Authors: Joao Paulo Solar Vasconcelos and Sharlene Gill
Dr. Sharlene Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver, Canada. Dr. Gill serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee and Chair of the UBC Department of Medicine Mentoring Committee. She is the Editor-in-Chief for Current Oncology and is the President of the Canadian Association of Medical Oncologists. Her TEDx talk in 2022 on ‘How to Flip the Script on Cancer’ delivered her passion for patient advocacy and empowerment.
More posts featuring Sharlene Gill.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023